Amag Pharmaceuticals, Inc.
Clinical trials sponsored by Amag Pharmaceuticals, Inc., explained in plain language.
-
New hope for anemic kids with kidney disease: safer iron therapy tested
Disease control Recruiting nowThis study tests a medicine called ferumoxytol to treat iron deficiency anemia in children aged 2 to 17 with chronic kidney disease. It compares ferumoxytol to another iron treatment (iron sucrose) to see which is safer and works better at raising hemoglobin levels. About 129 chi…
Phase: PHASE3 • Sponsor: AMAG Pharmaceuticals, Inc. • Aim: Disease control
Last updated May 15, 2026 12:07 UTC
-
New iron shot could help kids who Can't take pills
Disease control Recruiting nowThis study tests a medicine called ferumoxytol, given as an IV, to treat iron deficiency anemia in children aged 2 to 17. It is for kids who cannot take iron pills or for whom pills do not work well. The main goal is to see if the treatment raises hemoglobin levels after 5 weeks …
Phase: PHASE3 • Sponsor: AMAG Pharmaceuticals, Inc. • Aim: Disease control
Last updated May 11, 2026 20:50 UTC